A group of investors continued the United Headhealthcare group on Wednesday, accusing the company of having deceived them after the murder of its CEO, Brian Thompson.
Collective appeal – filed in the South New York district – accuses the Health Insurance Company of not initially adjusting their prospects for net earnings in 2025 to take into account the way in which Thompson’s murder would affect their operations.
On December 3 – One day before Thompson died dead – the company issued advice which included net profit from $ 28.15 to $ 28.65 per share and adjusted net profit from $ 29.50 to $ 30.00 per share, the pursuit. And on January 16, the company announced that it was standing for its old forecasts.
Investors have described this as “materially false and deceptive”, emphasizing the immense public examination of the company and the broader industry of health insurance felt in the wake of the murder of Thompson.
The group, which requires unpertified damages, argued that the public reaction prevented the company from continuing “the aggressive tactics and anti-consumption it would need to achieve” its profit objectives.
“As such, the company was deliberately reckless to double its advice previously issued,” said the trial.
The company finally revised its prospects for 2025 on April 17, citing a necessary change in the corporate strategy – a decision which lowered its shares by more than 22% that day.
“Society denies any allegation of reprehensible acts and intends to defend the question vigorously,” said a spokesperson for Unitedhealthcare in a statement.
Thompson’s deadly shooting in New York streets on Broad Daylight sent shock waves across the country.
Luigi Mangione, the 27 -year -old man accused of the murder, pleaded not guilty of the federal and state accusations against him. The Mangione Legal Defense Fund exceeded the million dollars of donations on Tuesday.
